TFR2 and acute myeloid leukemia: Notably, transferrin receptor 2 (TFR2) is also upregulated in different AML subtypes such as AML1, AML2, and erythroleukemia (AML6) (30, 31), and TFR2 α-subtype expression may be positively associated with a favorable prognosis (32).